The site of Leishmania major infection determines disease severity and immune responses.
about
Study of Leishmania pathogenesis in mice: experimental considerationsDendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex DiseaseIL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infectionThe evolution of trypanosomatid taxonomy.Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania majorConditions influencing the efficacy of vaccination with live organisms against Leishmania major infectionToward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensisThe skin immune atlas: three-dimensional analysis of cutaneous leukocyte subsets by multiphoton microscopy.Host genetic background influences the response to the opportunistic Pseudomonas aeruginosa infection altering cell-mediated immunity and bacterial replication.Indigenous microbiota and Leishmaniasis.Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice.Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse ear.Animal models of skin disease for drug discovery.The route of Leishmania tropica infection determines disease outcome and protection against Leishmania major in BALB/c miceEvaluation of s.c. route of immunization by homologous radio attenuated live vaccine in experimental murine model of visceral leishmaniasisDendritic cell populations in Leishmania major-infected skin and draining lymph nodesComplement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c miceUse of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis.Evaluation of an in vitro and in vivo model for experimental infection with Leishmania (Viannia) braziliensis and L. (V.) peruviana.Use of In Vivo Imaging System Technology in Leishmania major BALB/c Mouse Ear Infection Studies.Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major
P2860
Q26766230-74357CEC-A05B-471A-AA86-5C925AC5B173Q26767147-9DC5B94E-9FFF-49B2-9353-75CB5B77B568Q27335548-098D50C0-FBE7-42CF-BBDA-BD15831101C8Q33776260-26E57DA2-597D-4BD4-8D9A-41BE43F0E925Q33899666-81293CAA-0FB4-45DE-8E81-F79631DC6FDFQ33946585-8E99A535-F6C5-4300-9EBA-2BF09E3CCE46Q34033888-A4F93482-7A7A-4AC6-993D-6D5BE30CFA12Q34714925-44B1C059-BAF8-4213-8649-5783D27D87EFQ35288221-BC938B78-5764-4BA6-91B0-C2385114A6A2Q35788474-BC44B79E-27EE-4AB8-9EAC-021E4F35671FQ35884239-B28DBA1B-2943-4003-B73D-3A1E33A6E054Q36313776-D7053C19-E34D-40E7-92FC-32DE56517BEDQ36631641-18059092-4C5D-4D83-9CBB-51642EE19F01Q36655180-C5DF7036-EA35-4847-A73F-272284C51742Q37053213-8AE64997-5927-4759-8F9B-0A56B87F180DQ37117038-C1337E31-B810-4CD9-998D-458AAC8ED820Q37451138-3113585B-A1C3-4CCC-A1B0-FA06176DCA6EQ37720821-4C5089CC-7E46-40E0-8A27-B6AFFE5B6D38Q39016391-2F9322DA-C995-4939-8203-2511AEC3BE6AQ47290243-12802D52-EFB3-4B9C-9172-37571C5E1805Q48347654-478CA683-219A-47FD-8563-20F74C70607EQ56880374-FFA424FB-AF8E-4830-A9CE-C5B7D20BF24F
P2860
The site of Leishmania major infection determines disease severity and immune responses.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The site of Leishmania major infection determines disease severity and immune responses.
@ast
The site of Leishmania major infection determines disease severity and immune responses.
@en
The site of Leishmania major infection determines disease severity and immune responses.
@nl
type
label
The site of Leishmania major infection determines disease severity and immune responses.
@ast
The site of Leishmania major infection determines disease severity and immune responses.
@en
The site of Leishmania major infection determines disease severity and immune responses.
@nl
prefLabel
The site of Leishmania major infection determines disease severity and immune responses.
@ast
The site of Leishmania major infection determines disease severity and immune responses.
@en
The site of Leishmania major infection determines disease severity and immune responses.
@nl
P2093
P2860
P1476
The site of Leishmania major infection determines disease severity and immune responses.
@en
P2093
Colleen Elso
Emanuela Handman
Joan Curtis
Lynn Buckingham
Tracey M Baldwin
P2860
P304
P356
10.1128/IAI.71.12.6830-6834.2003
P407
P577
2003-12-01T00:00:00Z